SAN DIEGO -- The oral full-spectrum microbiome drug EBX-102-02 was well tolerated with mostly mild gastrointestinal adverse events and a trend toward less patient-reported pain and straining in those ...
PHOENIX -- A migraine medication targeting calcitonin gene-related peptide (CGRP) pathways wasn't shown to improve daily abdominal pain scores in irritable bowel syndrome (IBS), but it may help reduce ...
DEAR DR. ROACH: After a month of testing from my gastrointestinal doctor, I have been diagnosed with irritable bowel syndrome ...
Phase 2 of the clinical study for the drug eluxadoline showed improvements for patients with irritable bowel syndrome with diarrhea over the placebo treatment, according to a Healio report. The trial ...
Verywell Health on MSN
IBS vs. lactose intolerance: How can you tell the difference?
Medically reviewed by Robert Burakoff, MD Key Takeaways IBS and lactose intolerance both cause symptoms of diarrhea, ...
Preliminary shotgun metagenomic sequencing demonstrated that EBX-102-02 induced a broad and sustained shift in the gut ...
WASHINGTON -- A drug used to treat alcoholics and drug overdoses may also offer relief to people with irritable bowel syndrome. A small trial of 50 patients with the painful disorder found that ...
Israeli company RedHill Biopharma Ltd. released final results from the Phase II clinical study with Bekinda 12 milligrams for treatment of diarrhea-predominant irritable bowel syndrome. 1. RedHill is ...
Digestive woes like gastroparesis and IBS, though distinct, cause similar discomfort. Gastroparesis slows stomach emptying, leading to nausea and early fullness. IBS impacts the intestines with cramps ...
Verywell Health on MSN
How Stress Affects IBS-C and Ways to Get Relief
Learn why the gut–brain connection increases stress and affects IBS symptoms and explore evidence-based treatments like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback